Aspirin and age-related macular degeneration: positives versus negatives

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.13, Iss.6, 2014-06, pp. : 687-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Does aspirin increase the risk of age-related macular degeneration?

By Chong Elaine W Guymer Robyn H Robman Liubov D

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 691-693

Informa Healthcare

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?

By Christen William G Chew Emily Y

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 421-429

Informa Healthcare

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite

By Lacour M.

Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. : 101-133

Adis International

Access to resources Recommend Favorite